These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1891883)

  • 41. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
    Barber TL; Walton TE; Lewis KJ
    Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccines for Venezuelan equine encephalitis.
    Paessler S; Weaver SC
    Vaccine; 2009 Nov; 27 Suppl 4():D80-5. PubMed ID: 19837294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
    Phillpotts RJ
    Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Venezuelan equine encephalomyelitis: past, present, and future.
    McConnell S
    J Am Vet Med Assoc; 1972 Dec; 161(11):1579-83. PubMed ID: 4565076
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
    Arya SC
    Am J Trop Med Hyg; 2001 Dec; 65(6):v-vi. PubMed ID: 11792007
    [No Abstract]   [Full Text] [Related]  

  • 46. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
    Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
    PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transmissibility of an attenuated Venezuelan equine encephalomyelitis vaccine virus.
    Taylor WM; Buff E
    J Am Vet Med Assoc; 1972 Jul; 161(2):159-63. PubMed ID: 4402529
    [No Abstract]   [Full Text] [Related]  

  • 48. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics.
    Gonzalez-Salazar D; Estrada-Franco JG; Carrara AS; Aronson JF; Weaver SC
    Emerg Infect Dis; 2003 Feb; 9(2):161-8. PubMed ID: 12603985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epizootiology of Venezuelan equine encephalomyelitis in the Americas.
    Walton TE; Johnson KM
    J Am Vet Med Assoc; 1972 Dec; 161(11):1509-15. PubMed ID: 4404744
    [No Abstract]   [Full Text] [Related]  

  • 51. Preparation and evaluation of inactivated Venezuelan equine encephalitis vaccines.
    Mussgay M; Bergold GH; Weiland E; Ueberschär S
    Zentralbl Veterinarmed B; 1972 Jun; 19(6):511-7. PubMed ID: 4639187
    [No Abstract]   [Full Text] [Related]  

  • 52. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
    Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
    Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV.
    Phillpotts RJ; Lescott TL; Jacobs SC
    Acta Virol; 2000 Oct; 44(5):233-9. PubMed ID: 11252667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stability of RNA virus attenuation approaches.
    Kenney JL; Volk SM; Pandya J; Wang E; Liang X; Weaver SC
    Vaccine; 2011 Mar; 29(12):2230-4. PubMed ID: 21288800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection.
    Yao Z; Zanini F; Kumar S; Karim M; Saul S; Bhalla N; Panpradist N; Muniz A; Narayanan A; Quake SR; Einav S
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009306. PubMed ID: 33788849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Further observations on infections of guinea pigs with Venezuelan encephalitis virus strains.
    Scherer WF; Chin J; Ordonez JV
    Am J Trop Med Hyg; 1979 Jul; 28(4):725-8. PubMed ID: 464194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence of neutralizing antibody in Equidae vaccinated with Venezuelan equine encephalomyelitis vaccine strain TC-83.
    Walton TE; Johnson KM
    J Am Vet Med Assoc; 1972 Oct; 161(8):916-8. PubMed ID: 5074268
    [No Abstract]   [Full Text] [Related]  

  • 59. Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis.
    Jochim MM; Barber TL
    J Am Vet Med Assoc; 1974 Oct; 165(7):621-5. PubMed ID: 4422323
    [No Abstract]   [Full Text] [Related]  

  • 60. Venezuelan equine encephalitis virus: horse virulence of P-676 and MF-8 small and minute plaques.
    Justines G; Oro G; Alvarez O
    Am J Trop Med Hyg; 1981 Mar; 30(2):444-8. PubMed ID: 7235134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.